Zahravi Pharmacutical Co (XTEH:DZAH1) COGS-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co COGS-to-Revenue?

Zahravi Pharmacutical Co's Cost of Goods Sold for the six months ended in . 20 was IRR0.00 Mil. Its Revenue for the six months ended in . 20 was IRR0.00 Mil.

Zahravi Pharmacutical Co's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Zahravi Pharmacutical Co's Gross Margin % for the six months ended in . 20 was N/A%.

Zahravi Pharmacutical Co COGS-to-Revenue Historical Data

The historical data trend for Zahravi Pharmacutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co COGS-to-Revenue Chart

Zahravi Pharmacutical Co Annual Data

Trend

COGS-to-Revenue

Zahravi Pharmacutical Co Semi-Annual Data

COGS-to-Revenue

Zahravi Pharmacutical Co COGS-to-Revenue Calculation

Zahravi Pharmacutical Co's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Zahravi Pharmacutical Co's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Zahravi Pharmacutical Co (XTEH:DZAH1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Zahravi Pharmacutical Co's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	/
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Zahravi Pharmacutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN

Website

http://www.zahravi.com

Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines